Allianz Global Investors Fund - Allianz Europe Equity Growth A EUR WT4 USDRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | - | 7.2 | |
+/-Cat | - | - | - | - | 0.2 | |
+/-B’mrk | - | - | - | - | -1.6 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: MSCI Europe Growth NR EUR |
Key Stats | ||
NAV 29/04/2024 | USD 1098.97 | |
Day Change | 0.02% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
ISIN | LU2632654831 | |
Fund Size (Mil) 29/04/2024 | EUR 4041.17 | |
Share Class Size (Mil) 29/04/2024 | USD 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.53% |
Investment Objective: Allianz Global Investors Fund - Allianz Europe Equity Growth A EUR WT4 USD |
Long-term capital growth by investing in European equity markets with a focus on growth stocks. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Andreas Hildebrand 10/10/2023 | ||
Giovanni Trombello 10/10/2023 | ||
Click here to see others | ||
Inception Date 28/06/2023 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Europe LargeMidCap Growth NR USD | MSCI Europe Growth NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Europe Equity Growth A EUR WT4 USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 9.20 |
Novo Nordisk A/S Class B | Healthcare | 8.66 |
DSV AS | Industrials | 4.73 |
Sika AG | Basic Materials | 4.11 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 3.92 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Europe Equity Growth A EUR WT4 USD |